| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Echocardiography | 20 | 2024 | 1125 | 2.640 |
Why?
|
| Cardiology | 6 | 2026 | 514 | 1.440 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 5 | 2026 | 78 | 1.070 |
Why?
|
| Heart Defects, Congenital | 17 | 2024 | 1889 | 1.070 |
Why?
|
| Heart Diseases | 3 | 2026 | 499 | 0.910 |
Why?
|
| Coronary Aneurysm | 3 | 2026 | 35 | 0.880 |
Why?
|
| Echocardiography, Doppler | 6 | 2024 | 158 | 0.840 |
Why?
|
| Societies, Medical | 3 | 2021 | 798 | 0.840 |
Why?
|
| Fetal Heart | 6 | 2025 | 132 | 0.720 |
Why?
|
| Fetal Diseases | 5 | 2018 | 440 | 0.620 |
Why?
|
| Hypoplastic Left Heart Syndrome | 5 | 2025 | 261 | 0.590 |
Why?
|
| Heart Block | 1 | 2018 | 37 | 0.560 |
Why?
|
| Ventricular Function, Left | 6 | 2021 | 549 | 0.530 |
Why?
|
| Ultrasonography, Prenatal | 11 | 2026 | 986 | 0.470 |
Why?
|
| Vein of Galen Malformations | 2 | 2026 | 21 | 0.460 |
Why?
|
| Utilization Review | 1 | 2015 | 39 | 0.460 |
Why?
|
| Program Evaluation | 1 | 2017 | 447 | 0.450 |
Why?
|
| Clinical Competence | 3 | 2020 | 1050 | 0.430 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 689 | 0.430 |
Why?
|
| Diastole | 1 | 2015 | 181 | 0.430 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2015 | 77 | 0.420 |
Why?
|
| Heart Septal Defects, Atrial | 2 | 2026 | 138 | 0.410 |
Why?
|
| Heart Ventricles | 8 | 2022 | 749 | 0.410 |
Why?
|
| Pregnancy | 19 | 2026 | 7512 | 0.390 |
Why?
|
| Coronary Vessels | 1 | 2017 | 521 | 0.390 |
Why?
|
| Patient Safety | 2 | 2020 | 443 | 0.350 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2021 | 362 | 0.320 |
Why?
|
| Biomedical Research | 1 | 2015 | 561 | 0.290 |
Why?
|
| Humans | 56 | 2026 | 131163 | 0.280 |
Why?
|
| Internship and Residency | 2 | 2020 | 1223 | 0.280 |
Why?
|
| Pediatrics | 2 | 2017 | 1252 | 0.280 |
Why?
|
| Pediatricians | 3 | 2026 | 78 | 0.270 |
Why?
|
| Child | 21 | 2026 | 26341 | 0.250 |
Why?
|
| Infant, Newborn | 17 | 2025 | 8635 | 0.250 |
Why?
|
| Myocardial Contraction | 2 | 2019 | 241 | 0.240 |
Why?
|
| Immunoglobulins, Intravenous | 2 | 2019 | 148 | 0.240 |
Why?
|
| Predictive Value of Tests | 7 | 2026 | 2304 | 0.230 |
Why?
|
| School Nursing | 1 | 2026 | 12 | 0.230 |
Why?
|
| Fetofetal Transfusion | 2 | 2020 | 206 | 0.230 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2025 | 3763 | 0.230 |
Why?
|
| Tetralogy of Fallot | 2 | 2019 | 170 | 0.230 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2026 | 60 | 0.230 |
Why?
|
| Female | 37 | 2026 | 70963 | 0.230 |
Why?
|
| Atrial Septum | 1 | 2025 | 21 | 0.230 |
Why?
|
| Cardiac Catheterization | 2 | 2025 | 630 | 0.230 |
Why?
|
| Fetal Therapies | 1 | 2026 | 94 | 0.220 |
Why?
|
| Coronary Circulation | 1 | 2026 | 187 | 0.220 |
Why?
|
| Retrospective Studies | 20 | 2026 | 17753 | 0.200 |
Why?
|
| Resuscitation | 1 | 2026 | 258 | 0.200 |
Why?
|
| Embolization, Therapeutic | 1 | 2026 | 233 | 0.200 |
Why?
|
| Echocardiography, Transesophageal | 4 | 2020 | 246 | 0.200 |
Why?
|
| United States | 5 | 2024 | 12072 | 0.190 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2025 | 361 | 0.180 |
Why?
|
| Cardiovascular Diseases | 1 | 2015 | 2121 | 0.180 |
Why?
|
| Spinal Dysraphism | 1 | 2026 | 261 | 0.180 |
Why?
|
| Fetoscopy | 1 | 2026 | 460 | 0.170 |
Why?
|
| Vascular Diseases | 1 | 2022 | 146 | 0.170 |
Why?
|
| Echocardiography, Doppler, Color | 3 | 2016 | 113 | 0.160 |
Why?
|
| Education, Distance | 1 | 2020 | 69 | 0.150 |
Why?
|
| Postoperative Complications | 4 | 2016 | 3147 | 0.150 |
Why?
|
| Ventricular Function, Right | 2 | 2021 | 126 | 0.150 |
Why?
|
| Etanercept | 1 | 2019 | 44 | 0.150 |
Why?
|
| Gestational Age | 7 | 2025 | 1224 | 0.140 |
Why?
|
| Healthcare Disparities | 1 | 2024 | 523 | 0.140 |
Why?
|
| Pregnancy Outcome | 3 | 2016 | 623 | 0.140 |
Why?
|
| Preoperative Care | 1 | 2000 | 358 | 0.130 |
Why?
|
| Curriculum | 3 | 2020 | 798 | 0.130 |
Why?
|
| Endovascular Procedures | 1 | 2026 | 802 | 0.130 |
Why?
|
| Vascular Resistance | 1 | 2018 | 182 | 0.130 |
Why?
|
| Infant | 15 | 2026 | 13352 | 0.130 |
Why?
|
| Fetus | 3 | 2021 | 568 | 0.130 |
Why?
|
| Antibodies | 1 | 2018 | 322 | 0.130 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 292 | 0.130 |
Why?
|
| Torsion Abnormality | 1 | 2016 | 28 | 0.120 |
Why?
|
| Fellowships and Scholarships | 2 | 2017 | 327 | 0.120 |
Why?
|
| Patient Selection | 1 | 2000 | 729 | 0.120 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2000 | 400 | 0.120 |
Why?
|
| Ventricular Function | 1 | 2016 | 81 | 0.120 |
Why?
|
| Cardiac Output | 1 | 2016 | 153 | 0.120 |
Why?
|
| Male | 22 | 2026 | 64957 | 0.120 |
Why?
|
| Prospective Studies | 5 | 2020 | 6459 | 0.110 |
Why?
|
| Laser Coagulation | 1 | 2016 | 114 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 339 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 351 | 0.110 |
Why?
|
| Oxygen | 1 | 2018 | 548 | 0.110 |
Why?
|
| Cerebrovascular Circulation | 1 | 2018 | 487 | 0.110 |
Why?
|
| Hyperoxia | 1 | 2016 | 136 | 0.110 |
Why?
|
| Mitral Valve | 1 | 2016 | 247 | 0.110 |
Why?
|
| Congresses as Topic | 1 | 2015 | 184 | 0.100 |
Why?
|
| Ebstein Anomaly | 1 | 2014 | 29 | 0.100 |
Why?
|
| Reproducibility of Results | 5 | 2025 | 2904 | 0.100 |
Why?
|
| Hydrops Fetalis | 2 | 2012 | 82 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 1295 | 0.100 |
Why?
|
| Immunologic Factors | 1 | 2014 | 190 | 0.100 |
Why?
|
| Prenatal Diagnosis | 2 | 2020 | 612 | 0.090 |
Why?
|
| Child, Preschool | 11 | 2026 | 15110 | 0.090 |
Why?
|
| Aortic Valve Stenosis | 3 | 2016 | 350 | 0.090 |
Why?
|
| Education, Medical, Continuing | 1 | 2013 | 132 | 0.090 |
Why?
|
| Electroencephalography | 1 | 2016 | 863 | 0.090 |
Why?
|
| Cystic Adenomatoid Malformation of Lung, Congenital | 1 | 2012 | 18 | 0.090 |
Why?
|
| Adrenalectomy | 1 | 2012 | 30 | 0.090 |
Why?
|
| Pheochromocytoma | 1 | 2012 | 31 | 0.090 |
Why?
|
| Vascular Neoplasms | 1 | 2012 | 31 | 0.090 |
Why?
|
| Hemodynamics | 4 | 2022 | 810 | 0.090 |
Why?
|
| Aortic Valve | 2 | 2016 | 455 | 0.080 |
Why?
|
| Cardiomyopathies | 1 | 2016 | 514 | 0.080 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2012 | 64 | 0.080 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 567 | 0.080 |
Why?
|
| Risk Factors | 6 | 2026 | 11074 | 0.080 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2012 | 104 | 0.080 |
Why?
|
| Texas | 5 | 2016 | 3686 | 0.080 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2010 | 64 | 0.080 |
Why?
|
| Treatment Outcome | 9 | 2025 | 12936 | 0.080 |
Why?
|
| Infant, Low Birth Weight | 1 | 2010 | 172 | 0.080 |
Why?
|
| Umbilical Arteries | 2 | 2020 | 100 | 0.070 |
Why?
|
| Bioprosthesis | 1 | 2010 | 110 | 0.070 |
Why?
|
| Time Factors | 3 | 2026 | 6196 | 0.070 |
Why?
|
| Ultrasonography, Interventional | 1 | 2010 | 205 | 0.070 |
Why?
|
| Pericardium | 1 | 1989 | 103 | 0.070 |
Why?
|
| Adolescent | 11 | 2016 | 20987 | 0.070 |
Why?
|
| Stroke Volume | 4 | 2016 | 541 | 0.060 |
Why?
|
| Heart Valve Prosthesis | 1 | 2010 | 303 | 0.060 |
Why?
|
| Drug Resistance | 2 | 2019 | 242 | 0.060 |
Why?
|
| Risk Assessment | 2 | 2026 | 3711 | 0.060 |
Why?
|
| Return to Sport | 1 | 2026 | 9 | 0.060 |
Why?
|
| Fluoroscopy | 1 | 2026 | 108 | 0.060 |
Why?
|
| Sheep | 1 | 2026 | 229 | 0.060 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2010 | 425 | 0.060 |
Why?
|
| Syncope | 1 | 2026 | 52 | 0.060 |
Why?
|
| Albumins | 1 | 2005 | 87 | 0.060 |
Why?
|
| Chest Pain | 1 | 2026 | 133 | 0.050 |
Why?
|
| Infant, Premature | 1 | 2010 | 872 | 0.050 |
Why?
|
| Pericardial Effusion | 1 | 2005 | 78 | 0.050 |
Why?
|
| Longitudinal Studies | 2 | 2021 | 1490 | 0.050 |
Why?
|
| Fluorocarbons | 1 | 2005 | 66 | 0.050 |
Why?
|
| Myocarditis | 1 | 2026 | 122 | 0.050 |
Why?
|
| Vasodilator Agents | 1 | 2026 | 197 | 0.050 |
Why?
|
| Stents | 1 | 2010 | 799 | 0.050 |
Why?
|
| Endophthalmitis | 1 | 2004 | 49 | 0.050 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2026 | 208 | 0.050 |
Why?
|
| Family | 1 | 2007 | 589 | 0.050 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2007 | 500 | 0.050 |
Why?
|
| Hemangioma | 1 | 2004 | 86 | 0.050 |
Why?
|
| Transposition of Great Vessels | 1 | 2004 | 118 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2018 | 1445 | 0.050 |
Why?
|
| Endocarditis, Bacterial | 1 | 2004 | 128 | 0.050 |
Why?
|
| Meningomyelocele | 1 | 2026 | 260 | 0.050 |
Why?
|
| Acute Disease | 2 | 2019 | 1153 | 0.050 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2004 | 149 | 0.050 |
Why?
|
| Contrast Media | 1 | 2005 | 474 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2007 | 707 | 0.040 |
Why?
|
| Referral and Consultation | 1 | 2026 | 564 | 0.040 |
Why?
|
| Prognosis | 2 | 2026 | 4886 | 0.040 |
Why?
|
| Adult | 9 | 2026 | 31282 | 0.040 |
Why?
|
| Heart Atria | 2 | 2016 | 343 | 0.040 |
Why?
|
| Aorta | 1 | 2004 | 521 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2024 | 915 | 0.040 |
Why?
|
| Postoperative Care | 1 | 2022 | 294 | 0.040 |
Why?
|
| Pulmonary Artery | 2 | 2019 | 434 | 0.040 |
Why?
|
| Hospital Charges | 1 | 2000 | 70 | 0.040 |
Why?
|
| Occupational Health | 1 | 2020 | 43 | 0.040 |
Why?
|
| Elective Surgical Procedures | 1 | 2000 | 162 | 0.040 |
Why?
|
| Ultrasonography, Doppler | 1 | 2020 | 187 | 0.040 |
Why?
|
| Recovery of Function | 2 | 2012 | 449 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 2000 | 928 | 0.040 |
Why?
|
| Infection Control | 1 | 2020 | 158 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2000 | 787 | 0.040 |
Why?
|
| Palliative Care | 1 | 2022 | 443 | 0.030 |
Why?
|
| Pulsatile Flow | 1 | 2018 | 110 | 0.030 |
Why?
|
| Follow-Up Studies | 4 | 2016 | 5196 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 2019 | 279 | 0.030 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2018 | 85 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2024 | 712 | 0.030 |
Why?
|
| Drug Therapy, Combination | 2 | 2019 | 1173 | 0.030 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 1998 | 110 | 0.030 |
Why?
|
| Aortic Coarctation | 1 | 1998 | 99 | 0.030 |
Why?
|
| Torsion, Mechanical | 1 | 2016 | 6 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 1997 | 145 | 0.030 |
Why?
|
| Survival Rate | 2 | 2016 | 2114 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2018 | 761 | 0.030 |
Why?
|
| Time | 1 | 2016 | 92 | 0.030 |
Why?
|
| Perinatal Mortality | 1 | 2016 | 44 | 0.030 |
Why?
|
| Hand Deformities, Congenital | 1 | 1997 | 96 | 0.030 |
Why?
|
| Twins | 1 | 2016 | 70 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 2004 | 909 | 0.030 |
Why?
|
| Tensile Strength | 1 | 2016 | 47 | 0.030 |
Why?
|
| Elastic Modulus | 1 | 2016 | 31 | 0.030 |
Why?
|
| Reference Standards | 1 | 2016 | 231 | 0.030 |
Why?
|
| Systole | 1 | 2016 | 195 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 2085 | 0.030 |
Why?
|
| Craniofacial Abnormalities | 1 | 1997 | 251 | 0.030 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2004 | 1168 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2016 | 178 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2019 | 1626 | 0.030 |
Why?
|
| Radiography | 2 | 2004 | 743 | 0.030 |
Why?
|
| Reference Values | 1 | 2016 | 676 | 0.030 |
Why?
|
| Length of Stay | 1 | 2000 | 1421 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 1997 | 653 | 0.030 |
Why?
|
| Ultrasonography | 2 | 2012 | 943 | 0.030 |
Why?
|
| Renal Dialysis | 1 | 2021 | 951 | 0.030 |
Why?
|
| ROC Curve | 1 | 2016 | 613 | 0.030 |
Why?
|
| Pyrazinamide | 1 | 1993 | 10 | 0.030 |
Why?
|
| Streptomycin | 1 | 1993 | 11 | 0.030 |
Why?
|
| Ethambutol | 1 | 1993 | 7 | 0.030 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2013 | 51 | 0.020 |
Why?
|
| Heart Septal Defects, Ventricular | 2 | 2004 | 132 | 0.020 |
Why?
|
| Learning Curve | 1 | 2013 | 54 | 0.020 |
Why?
|
| Isoniazid | 1 | 1993 | 69 | 0.020 |
Why?
|
| Pandemics | 1 | 2020 | 1118 | 0.020 |
Why?
|
| Age Factors | 1 | 2019 | 2825 | 0.020 |
Why?
|
| Rifampin | 1 | 1993 | 128 | 0.020 |
Why?
|
| Self Efficacy | 1 | 2013 | 211 | 0.020 |
Why?
|
| Abnormalities, Multiple | 1 | 1997 | 963 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2014 | 3061 | 0.020 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 1993 | 157 | 0.020 |
Why?
|
| Heart Aneurysm | 1 | 1991 | 27 | 0.020 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 1991 | 36 | 0.020 |
Why?
|
| Myocardium | 1 | 2016 | 852 | 0.020 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2012 | 227 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 3829 | 0.020 |
Why?
|
| Radiography, Interventional | 1 | 2010 | 79 | 0.020 |
Why?
|
| Cardiopulmonary Bypass | 1 | 1991 | 361 | 0.020 |
Why?
|
| Animals | 2 | 2026 | 33912 | 0.020 |
Why?
|
| Antihypertensive Agents | 1 | 2012 | 414 | 0.020 |
Why?
|
| Blood Flow Velocity | 2 | 2005 | 417 | 0.020 |
Why?
|
| Aging | 1 | 2016 | 1242 | 0.020 |
Why?
|
| Abortion, Eugenic | 1 | 2008 | 10 | 0.020 |
Why?
|
| Hernia, Umbilical | 1 | 2008 | 40 | 0.020 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2008 | 91 | 0.020 |
Why?
|
| Pericardiocentesis | 1 | 2007 | 17 | 0.020 |
Why?
|
| Chest Tubes | 1 | 2007 | 38 | 0.020 |
Why?
|
| Organizational Policy | 1 | 2007 | 50 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2010 | 643 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2016 | 5063 | 0.020 |
Why?
|
| Brain | 1 | 2018 | 3175 | 0.020 |
Why?
|
| Swine | 1 | 2010 | 1186 | 0.010 |
Why?
|
| Catheterization, Central Venous | 1 | 2007 | 143 | 0.010 |
Why?
|
| Reoperation | 2 | 2004 | 818 | 0.010 |
Why?
|
| Intubation, Intratracheal | 1 | 2007 | 212 | 0.010 |
Why?
|
| Microspheres | 1 | 2005 | 66 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2005 | 239 | 0.010 |
Why?
|
| Fetal Death | 1 | 2005 | 115 | 0.010 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2007 | 229 | 0.010 |
Why?
|
| Infant Welfare | 1 | 2004 | 25 | 0.010 |
Why?
|
| Observer Variation | 1 | 2005 | 311 | 0.010 |
Why?
|
| Double Outlet Right Ventricle | 1 | 2004 | 19 | 0.010 |
Why?
|
| Central Nervous System Venous Angioma | 1 | 2004 | 2 | 0.010 |
Why?
|
| Tracheal Neoplasms | 1 | 2004 | 21 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2004 | 176 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2004 | 242 | 0.010 |
Why?
|
| Pulmonary Valve | 1 | 2004 | 83 | 0.010 |
Why?
|
| Surveys and Questionnaires | 2 | 2007 | 4066 | 0.010 |
Why?
|
| Patient Care Team | 1 | 2007 | 562 | 0.010 |
Why?
|
| Abscess | 1 | 2004 | 135 | 0.010 |
Why?
|
| Heart Valve Diseases | 1 | 2004 | 162 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 2005 | 573 | 0.010 |
Why?
|
| Aortic Diseases | 1 | 2004 | 190 | 0.010 |
Why?
|
| Young Adult | 1 | 2016 | 10103 | 0.010 |
Why?
|
| Syndrome | 1 | 2004 | 1155 | 0.010 |
Why?
|
| Maternal Age | 1 | 2001 | 136 | 0.010 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2004 | 279 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2004 | 1882 | 0.010 |
Why?
|
| Chromosome Banding | 1 | 1997 | 135 | 0.010 |
Why?
|
| Angioplasty, Balloon | 1 | 1998 | 122 | 0.010 |
Why?
|
| Karyotyping | 1 | 1997 | 308 | 0.010 |
Why?
|
| Intraoperative Period | 1 | 1996 | 63 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1996 | 225 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2004 | 1373 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1993 | 1618 | 0.000 |
Why?
|
| Phenotype | 1 | 1997 | 4497 | 0.000 |
Why?
|
| Tuberculosis | 1 | 1993 | 550 | 0.000 |
Why?
|
| Middle Aged | 2 | 1996 | 28601 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1993 | 6797 | 0.000 |
Why?
|
| Aged | 1 | 1993 | 21025 | 0.000 |
Why?
|